Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
MedTech
Guardant360-guided breast cancer therapy swaps boost survival
A new study suggests using the Guardant360 CDx test to inform a treatment change could slash the risk of breast cancer progression or death by half.
Andrea Park
Jun 3, 2025 10:00am
OSE shares 65% OS rate behind cancer vaccine's phase 2 win
Jun 3, 2025 7:05am
ASCO: Kura, Kyowa reveal 23% remission rate behind leukemia win
Jun 2, 2025 5:36pm
Bicara CEO: ASCO data resonate more with 'people that matter'
Jun 2, 2025 4:26pm
Actuate's pancreatic cancer drug boosts survival by 3 months
Jun 2, 2025 7:30am
AstraZeneca's breast cancer pill boosts PFS by 56% in phase 3
Jun 2, 2025 7:10am
